Unlock instant, AI-driven research and patent intelligence for your innovation.

Stable interferon microneedle preparation as well as preparation method and application thereof

A technology of microneedle preparation and interferon, which is applied in the field of medicine, can solve the problems of high transportation cost, inconvenient administration, and strict storage conditions of interferon, and achieve high activity, effective maintenance of activity, and reduced use cost

Active Publication Date: 2021-11-05
BEIJING TRI PRIME GENE PHARMA CO LTD +1
View PDF17 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The purpose of the present invention is to provide a stable interferon microneedle preparation to solve the problems of human interferon, such as high transportation cost, inconvenient administration, and strict storage conditions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable interferon microneedle preparation as well as preparation method and application thereof
  • Stable interferon microneedle preparation as well as preparation method and application thereof
  • Stable interferon microneedle preparation as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1 Integrated Dissolving Microneedle of Human Interferon α1b

[0054] This embodiment firstly provides an integrated dissolving microneedle for human interferon α1b, the preparation method of which is as follows:

[0055] 1. Preparation of microneedle matrix solution:

[0056] The microneedle matrix solution was prepared according to the following solid content ratio: 20% CMC, 5% trehalose, and 5% sucrose. Weigh CMC (sodium carboxymethylcellulose, viscosity 800cps, Anhui Shanhe Pharmaceutical Excipients Co., Ltd.) 0.2g, trehalose 0.05g, sucrose 0.05g, add 0.7mL PBS solution (0.01M, pH6.0) solution, After stirring and dissolving, let stand at 0°C for 5 minutes, centrifuge to remove air bubbles, add 0.042mL of 6mg / mL human interferon α1b stock solution, vortex and oscillate to mix, then centrifuge at 4°C to remove air bubbles, and place at 4°C to stand for use . At this time, the concentration of interferon α1b in the solution was 0.252 mg / mL.

[0057] 2. Micro...

Embodiment 4~7、 comparative example 8~12

[0070] Examples 4-7, Comparative Examples 8-12: Integrated dissolving microneedles containing different stabilizers

[0071] According to the preparation method of Example 1, according to the weight percentage of the substances given in Table 2, the microneedles of Examples 4-7 and Comparative Examples 8-12 were prepared and the microneedle integrity, puncture property, needle body color and biological Molecular activity (see Table 2).

[0072] It can be seen from Table 2 that Examples 4-5 and Comparative Examples 8-12 used similar microneedle matrix materials and single-component stabilizers. The microneedles containing calcium glucoheptonate and L-methionine showed different degrees of color change, and did not meet the standard in appearance; the interferon activity of microneedles containing EDTA, arginine and dextran was lower than 80 %; Microneedles containing trehalose and sucrose have good appearance, microneedle penetration and stability. Different microneedle matri...

Embodiment 8

[0075] Example 8: Layered Dissolving Microneedles of Human Interferon α1b

[0076] This embodiment provides a layered dissolving microneedle of human interferon α1b, the preparation method of which is as follows:

[0077] 1. Preparation of needle tip solution:

[0078] The activity results in Examples 2 and 3 show that CMC and PVA can play a role in stabilizing interferon α1b when used as microneedle substrates, so these two materials will be preferred as needle tip substrate materials when making split needles. When layering microneedles, the drying speed of CMC is faster than that of PVA, which is more conducive to stabilizing the active ingredients of the needle tip, so CMC is preferred as the matrix material of the needle tip.

[0079] The microneedle tip solution was prepared according to the following solid content ratio: 5% CMC, 5% trehalose, and 5% sucrose. Weigh 0.05g of CMC, 0.05g of trehalose, 0.05g of sucrose, add 0.85mL of PBS solution (0.01M, pH6.0) solution, s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicines, in particular to a stable interferon microneedle preparation as well as a preparation method and application thereof. The microneedle preparation contains interferon and an excipient, and the excipient mainly contains one or a mixture of sodium carboxymethyl cellulose and polyvinyl alcohol. According to the microneedle preparation, the interferon can keep high activity for a long time in a normal-temperature and normal-humidity environment, the microneedle preparation can be widely applied to different transdermal drug delivery preparation dosage forms including but not limited to an integrated microneedle, a layered microneedle, a needle tip coating microneedle and the like, normal-temperature transportation and storage of the interferon microneedle can be basically achieved, and the use cost of the medicinal preparation is greatly reduced.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a stable interferon microneedle preparation and its preparation method and application. Background technique [0002] Interferon is a kind of natural cytokine existing in the human body. It is an important part of innate immune response. It has three functions of anti-virus, anti-tumor and immune regulation. Human interferon-α has been widely used in hepatitis, virus Clinical treatment of diseases and blood (or solid) tumors. Interferon α exerts its antiviral function mainly by inducing cells to produce a variety of antiviral proteins and effectively inhibiting the replication of viruses in cells. Its indications in the field of viral skin disease treatment include herpes simplex, herpes zoster and human papilloma Viral skin warts (flat warts, common warts, genital warts, etc.) caused by viruses (HPV), etc. Currently clinically used human interferon-α dosage forms mainly include injecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/21A61K9/00A61K47/38A61K47/32A61K47/26A61K47/02A61K47/12A61P31/20A61M37/00
CPCA61K38/212A61K38/215A61K38/217A61K38/21A61K9/0021A61K47/38A61K47/32A61K47/26A61K47/02A61K47/12A61P31/20A61M37/0015A61M2037/0046A61M2037/0053
Inventor 程永庆高云华王召静周泽荃孙纪慧张锁慧刘金毅杨国忠林福玉
Owner BEIJING TRI PRIME GENE PHARMA CO LTD